Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier
- PMID: 3553005
- PMCID: PMC260542
- DOI: 10.1128/iai.55.6.1498-1502.1987
Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier
Abstract
Four synthetic peptides that copy fragments of two bacterial antigens (Streptococcus pyogenes M protein and diphtheria toxin), one viral antigen (hepatitis B surface antigen), and one parasitic antigen (circumsporozoite protein of Plasmodium knowlesi) were covalently bound within the same construct. This totally synthetic polyvalent administered to mice with Freund complete adjuvant or in saline with murabutide (an adjuvant-active muramyl peptide) elicited high levels of antibodies which, in certain cases, were shown to be biologically active. The results indicated that these antibodies recognized specifically the four peptides. None of the epitopes were immunodominant. It was also demonstrated that the association of several peptides enhanced their respective immunogenicities as compared with those of their homopolymers. Finally, this study shows that a totally synthetic vaccine administered in saline with a synthetic adjuvant can be immunogenic in the absence of a protein carrier.
Similar articles
-
Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.Biochem Biophys Res Commun. 1986 Oct 30;140(2):557-64. doi: 10.1016/0006-291x(86)90768-0. Biochem Biophys Res Commun. 1986. PMID: 3778467
-
Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.Infect Immun. 1985 Jun;48(3):839-42. doi: 10.1128/iai.48.3.839-842.1985. Infect Immun. 1985. PMID: 3997250 Free PMC article.
-
Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.Vaccine. 1999 Jan;17(2):193-200. doi: 10.1016/s0264-410x(98)00150-9. Vaccine. 1999. PMID: 9987154
-
Role of muramyl peptides for the enhancement of synthetic vaccines.Dev Biol Stand. 1986;63:133-40. Dev Biol Stand. 1986. PMID: 3527818 Review.
-
Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.J Biotechnol. 1996 Jan 26;44(1-3):91-6. doi: 10.1016/0168-1656(95)00118-2. J Biotechnol. 1996. PMID: 8717391 Review.
Cited by
-
Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.Infect Immun. 1987 Nov;55(11):2658-61. doi: 10.1128/iai.55.11.2658-2661.1987. Infect Immun. 1987. PMID: 2444539 Free PMC article.
-
Current approaches to vaccine preparation.Can Vet J. 1990 Mar;31(3):181-9. Can Vet J. 1990. PMID: 17423533 Free PMC article.
-
Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.Infect Immun. 1989 Jun;57(6):1845-8. doi: 10.1128/iai.57.6.1845-1848.1989. Infect Immun. 1989. PMID: 2785963 Free PMC article.
-
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization.Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6868-72. doi: 10.1073/pnas.92.15.6868. Proc Natl Acad Sci U S A. 1995. PMID: 7624334 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources